The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 ...

The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID ... The FDA’s approval of the vaccine comes as the federal agency announced ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the ...

Which brings us to today. The US Food and Drug Administration (FDA) has just approved an updated version of Novavax’s ...

The newest, updated Covid-19 vaccines are now FDA-approved and available, including the mRNA ones from Pfizer-BioNTech and ...

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 years of ...

Also Read: FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax’s Shot. “Our updated vaccine targets JN.1, the ‘parent strain’ of currently circulating ...